High-Density Lipoprotein Cholesterol Concentrations and Particle Size Are Modified by Dietary Zinc in Men

Objective To measure biomarkers of lipid metabolism in response to a marginal zinc depletion, repletion, and supplementation in healthy male subjects. Methods Eighteen male subjects between ages of 18–45 consumed a controlled diet (80% carbohydrate, 10% fat, 10% protein) with two levels of dietary z...

Full description

Bibliographic Details
Main Authors: Shenvi, Swapna, Chen, Kevin, Kim, Elijah, Zyba, Sarah, King, Sarah, Shigenaga, Mark, Killilea, David, Holland, Tai, Sutherland, Barbara, Krauss, Ronald, King, Janet C.
Format: Journal Article
Language:Inglés
Published: 2017
Subjects:
Online Access:https://hdl.handle.net/10568/171043
_version_ 1855530971803156480
author Shenvi, Swapna
Chen, Kevin
Kim, Elijah
Zyba, Sarah
King, Sarah
Shigenaga, Mark
Killilea, David
Holland, Tai
Sutherland, Barbara
Krauss, Ronald
King, Janet C.
author_browse Chen, Kevin
Holland, Tai
Killilea, David
Kim, Elijah
King, Janet C.
King, Sarah
Krauss, Ronald
Shenvi, Swapna
Shigenaga, Mark
Sutherland, Barbara
Zyba, Sarah
author_facet Shenvi, Swapna
Chen, Kevin
Kim, Elijah
Zyba, Sarah
King, Sarah
Shigenaga, Mark
Killilea, David
Holland, Tai
Sutherland, Barbara
Krauss, Ronald
King, Janet C.
author_sort Shenvi, Swapna
collection Repository of Agricultural Research Outputs (CGSpace)
description Objective To measure biomarkers of lipid metabolism in response to a marginal zinc depletion, repletion, and supplementation in healthy male subjects. Methods Eighteen male subjects between ages of 18–45 consumed a controlled diet (80% carbohydrate, 10% fat, 10% protein) with two levels of dietary zinc. Phase I: Low zinc: 6 mg/day with 1.5 mg of phytate (2 weeks); Phase II: Zinc repletion: 10 mg/day with no phytate (4 weeks). Thereafter, a 25 mg/day zinc supplement was administered with an ad libitum diet for 3 weeks (Phase III). Targeted analysis of lipids and lipoprotein particle size were performed using standard methodology. Results Plasma zinc levels remained unchanged during Phases I and II in all subjects; they increased by 17.4 ± 3.8% (mean ± SE) at the end of supplementation (phase III). Apo-A1 decreased significantly from 119.2 ± 13.2 mg/dL (mean ± SD) to 110.2 ± 13.2 mg/dL (p=0.003) at the end of the low zinc period. Apo-A1 remained low at the end of phase II, but returned back to baseline after supplementation. A similar pattern was observed in HDL-c and HDL-L (large buoyant HDL particles) levels across the three phases. Plasma triglyceride levels increased during the 6-week high-carbohydrate diet, but were not modified by shifts in dietary zinc. Based on our previous observation of higher DNA strand breaks in the low zinc metabolic period and literature reports linking cancer to low HDL-c levels, we performed a correlation analysis of DNA strand breaks and HDL subspecies. Our results show that the percent changes in HDL-L and DNA strand breaks from phase I to II are negatively correlated (r=−0.45; p=0.05). Conclusion Results from our studies show that low zinc combined with a high carbohydrate diet increased biomarkers of dyslipidemia, but provision of adequate dietary zinc or a zinc supplement for a short period of time mitigated the increase in these biomarkers. Support or Funding Information Harvest Plus
format Journal Article
id CGSpace171043
institution CGIAR Consortium
language Inglés
publishDate 2017
publishDateRange 2017
publishDateSort 2017
record_format dspace
spelling CGSpace1710432025-03-25T15:49:14Z High-Density Lipoprotein Cholesterol Concentrations and Particle Size Are Modified by Dietary Zinc in Men Shenvi, Swapna Chen, Kevin Kim, Elijah Zyba, Sarah King, Sarah Shigenaga, Mark Killilea, David Holland, Tai Sutherland, Barbara Krauss, Ronald King, Janet C. zinc organic matter nutrient intake Objective To measure biomarkers of lipid metabolism in response to a marginal zinc depletion, repletion, and supplementation in healthy male subjects. Methods Eighteen male subjects between ages of 18–45 consumed a controlled diet (80% carbohydrate, 10% fat, 10% protein) with two levels of dietary zinc. Phase I: Low zinc: 6 mg/day with 1.5 mg of phytate (2 weeks); Phase II: Zinc repletion: 10 mg/day with no phytate (4 weeks). Thereafter, a 25 mg/day zinc supplement was administered with an ad libitum diet for 3 weeks (Phase III). Targeted analysis of lipids and lipoprotein particle size were performed using standard methodology. Results Plasma zinc levels remained unchanged during Phases I and II in all subjects; they increased by 17.4 ± 3.8% (mean ± SE) at the end of supplementation (phase III). Apo-A1 decreased significantly from 119.2 ± 13.2 mg/dL (mean ± SD) to 110.2 ± 13.2 mg/dL (p=0.003) at the end of the low zinc period. Apo-A1 remained low at the end of phase II, but returned back to baseline after supplementation. A similar pattern was observed in HDL-c and HDL-L (large buoyant HDL particles) levels across the three phases. Plasma triglyceride levels increased during the 6-week high-carbohydrate diet, but were not modified by shifts in dietary zinc. Based on our previous observation of higher DNA strand breaks in the low zinc metabolic period and literature reports linking cancer to low HDL-c levels, we performed a correlation analysis of DNA strand breaks and HDL subspecies. Our results show that the percent changes in HDL-L and DNA strand breaks from phase I to II are negatively correlated (r=−0.45; p=0.05). Conclusion Results from our studies show that low zinc combined with a high carbohydrate diet increased biomarkers of dyslipidemia, but provision of adequate dietary zinc or a zinc supplement for a short period of time mitigated the increase in these biomarkers. Support or Funding Information Harvest Plus 2017 2025-01-29T12:57:38Z 2025-01-29T12:57:38Z Journal Article https://hdl.handle.net/10568/171043 en Limited Access Shenvi, Swapna; Chen, Kevin; Kim, Elijah; Zyba, Sarah; King, Sarah; Shigenaga, Mark; Killilea, David; Holland, Tai; Sutherland, Barbara; Krauss, Ronald; and King, Janet. 2017; High-Density Lipoprotein Cholesterol Concentrations and Particle Size Are Modified by Dietary Zinc in Men. FASEB Journal 31(S1): 802. https://doi.org/10.1096/fasebj.31.1_supplement.802.10
spellingShingle zinc
organic matter
nutrient intake
Shenvi, Swapna
Chen, Kevin
Kim, Elijah
Zyba, Sarah
King, Sarah
Shigenaga, Mark
Killilea, David
Holland, Tai
Sutherland, Barbara
Krauss, Ronald
King, Janet C.
High-Density Lipoprotein Cholesterol Concentrations and Particle Size Are Modified by Dietary Zinc in Men
title High-Density Lipoprotein Cholesterol Concentrations and Particle Size Are Modified by Dietary Zinc in Men
title_full High-Density Lipoprotein Cholesterol Concentrations and Particle Size Are Modified by Dietary Zinc in Men
title_fullStr High-Density Lipoprotein Cholesterol Concentrations and Particle Size Are Modified by Dietary Zinc in Men
title_full_unstemmed High-Density Lipoprotein Cholesterol Concentrations and Particle Size Are Modified by Dietary Zinc in Men
title_short High-Density Lipoprotein Cholesterol Concentrations and Particle Size Are Modified by Dietary Zinc in Men
title_sort high density lipoprotein cholesterol concentrations and particle size are modified by dietary zinc in men
topic zinc
organic matter
nutrient intake
url https://hdl.handle.net/10568/171043
work_keys_str_mv AT shenviswapna highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT chenkevin highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT kimelijah highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT zybasarah highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT kingsarah highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT shigenagamark highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT killileadavid highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT hollandtai highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT sutherlandbarbara highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT kraussronald highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen
AT kingjanetc highdensitylipoproteincholesterolconcentrationsandparticlesizearemodifiedbydietaryzincinmen